RBC Maintains Outperform Rating on Ascendis Pharma (ASND) Amid Growth Targets

30 1 月, 2026

One Min Read

7 Views

原文: https://finance.yahoo.com/news/rbc-maintains-outperform-rating-ascendis-070707126.html

Last Update: 30 1 月, 2026

Written By

Other Articles

Previous

Argenx’s (ARGX) Vyvgart Sales Outperform Expectations Across MG and CIDP Treatments

Next

<div>Stifel Initiates Hold on Genius Sports (GENI) as “Picks & Shovels” Model Strengthens Industry Position</div>

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept